Location: Home > Pharma China Web Edition
  • search
  • go
  • Feature Articles
  • 11/11/2024China Biotech and the Bear: A Perspective (BioCentury)
  • 11/11/2024Trump’s Trade Tango Returns: Will China’s Biotech Dance Through Anot...
  • 11/11/2024China Biopharma Tracker – October 2024 (PharmaDJ)
  • 11/7/2024Stimulus Package vs. Drug Price Negotiation, Impacts on China's Health...
  • 11/5/2024Landmark Whistleblower Program for China's Healthcare Sector: Proposed...
  • 11/4/2024Big Pharma Doubles Down on China (The Wire China)
  • 11/4/2024How AstraZeneca Bilked China's Insurance Program Out of CNY Millions (...
  • 11/4/2024Probe of AstraZeneca Executive in China Raises Questions about Company...
  • 10/31/2024China Investigation of Drug Firm Exec Deals Latest Blow to Foreign Bus...
  • 10/31/2024AstraZeneca's China Legal Woes Follow Push For Market Share (Bloomberg...
  • 10/30/2024China's Compliance Guidelines for Healthcare Companies Signal Areas of...
  • 10/29/2024VCs Move to Launch U.S.-Based Companies to Advance Drugs Developed in ...
  • 10/24/2024Patent Term Extensions In China: Overviews And Takeaways (Mondaq)
  • 10/24/2024Reinventing Your China Strategy: A Podcast Preview of the China Health...
  • 10/24/2024U.S. and China Compete for Top Position in the Global Drug Development...
  • 10/21/2024Changing Chinese Market Dynamics Hit Merck Where It Hurts (SCRIP Citel...
  • 10/21/2024Clinical Benefit, Price, and Regulatory Approval of Cancer Drugs Grant...
  • 10/16/2024As U.S. Efforts Stall, China Pushes Ahead with CRISPR Treatments for M...
  • 10/16/2024Understanding the NewCo Model: A Trending Approach of Chinese Pharmace...
  • 10/16/2024China Biopharma Tracker – Q3 2024 (PharmaDJ)
  • 10/16/2024China's New Policies On Foreign Investment In Healthcare And Biotechno...
  • 10/8/2024NRDL China: 2024 Outlook (Simon Kucher)
  • 10/1/2024China's Pharmaceutical Antimonopoly Guidelines Pose New Challenges for...
  • 9/27/2024Pharma Companies in Beijing Free Trade Zone to Benefit from Relaxed Da...
  • 9/23/2024Is Biotech the Next Battleground in US-China Decoupling? (SCMP)
  • 9/20/2024Why 'Big Pharma' Will be the Next China Trade War Battleground (Invest...
  • 9/20/2024Another Twist in the Biosecure Drama Leaves Bill's Fate Uncertain
  • 9/19/2024China's Implementation of Patent Term Adjustment (SM)
  • 9/17/2024Biopharma Prepares to Pivot from China as Biosecure Act Advances (Phar...
  • 9/17/2024NHC's Annual Statistical Report on China Healthcare Sector Development...
  • Page:1/7 Total number of articles:187: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group